Whether an insurer's use of a chiropractors' peer-review committee to advise on the necessity of treatment and reasonableness of fees is the "business of insurance" exempt from federal antitrust law under § 2(b) of the McCarran-Ferguson Act.
Holding
No. ULL's use of the New York State Chiropractic Association's Peer Review Committee was not the "business of insurance" and therefore did not receive the McCarran-Ferguson Act's antitrust exemption.
Reasoning
The Court treated Royal Drug as controlling. Because antitrust exemptions are construed narrowly, the statutory phrase exempts the "business of insurance," not every activity undertaken by an insurance company. Royal Drug identified three relevant, though not individually conclusive, considerations: whether a practice transfers or spreads policyholder risk, whether it is integral to the insurer-insured policy relationship, and whether it is confined to entities within the insurance industry.
Peer review did not transfer or spread risk. The insurance policy transfers the covered risk when the insurer and insured enter their contract. A policy's limitation to necessary treatments and reasonable charges defines the risk the insurer assumed from the start; expenses outside those limits remain the insured's risk. The later peer-review process merely helps determine whether a particular claim falls within those already-established policy limits.
The arrangement also was not an integral part of the policy relationship between ULL and its insureds. It was a separate agreement between ULL and a professional association of chiropractors. Although peer review might help ULL decide whether to pay a claim, the policyholder's concern is whether the insurer honors its contractual promise, not the insurer's chosen internal or external method for making that decision. Treating every cost-saving or claim-evaluation practice as insurance would improperly convert the exemption for the business of insurance into an exemption for the business of insurance companies.
Finally, the practice was not confined to the insurance industry. It necessarily involved practicing chiropractors, who were outside that industry. This fact was not alone dispositive, but it mattered because Congress's central concern in enacting the exemption was protecting intra-industry cooperation in underwriting risks. Arrangements with outside providers also can restrain competition in noninsurance markets, precisely the danger alleged here in the market for chiropractic services.
Because the peer-review arrangement failed the business-of-insurance inquiry, the Court did not need to decide whether New York regulated the conduct sufficiently or whether the alleged conduct involved boycott, coercion, or intimidation. The Court stressed that its ruling did not establish that petitioners had violated the Sherman Act; it held only that the conduct was not immune from antitrust scrutiny under McCarran-Ferguson.